Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
Krop IE, Jegede OA, Grilley-Olson JE, Lauring JD, Mitchell EP, Zwiebel JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Kono SA, Ford JM, Garcia AA, Sui XD, Siegel RD, Slomovitz BM, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Krop IE, et al. Among authors: grilley olson je. JCO Precis Oncol. 2022 Feb;6:e2100424. doi: 10.1200/PO.21.00424. JCO Precis Oncol. 2022. PMID: 35138919 Free PMC article. Clinical Trial.
PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation.
Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B, Blumberg JM, Patel SN, Weissler MC, Yarbrough WG, Sheets NC, Parker JS, Neil Hayes D, Weck KE, Ramkissoon LA, Mendenhall WM, Dagan R, Tan X, Gupta GP, Chera BS. Beaty BT, et al. J Natl Cancer Inst. 2020 Aug 1;112(8):855-858. doi: 10.1093/jnci/djz224. J Natl Cancer Inst. 2020. PMID: 31747025
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype.
Kardos J, Wobker SE, Woods ME, Nielsen ME, Smith AB, Wallen EM, Pruthi RS, Hayward MC, McGinty KA, Grilley-Olson JE, Patel NM, Weck KE, Black P, Parker JS, Milowsky MI, Hayes DN, Kim WY. Kardos J, et al. JCO Precis Oncol. 2017 Jul 6;1:PO.17.00027. doi: 10.1200/PO.17.00027. eCollection 2017. JCO Precis Oncol. 2017. PMID: 32913973 Free PMC article.
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
Chera BS, Sheth SH, Patel SA, Goldin D, Douglas KE, Green RL, Shen CJ, Gupta GP, Moore DT, Grilley Olson JE, Weiss JM. Chera BS, et al. Among authors: grilley olson je. Cancer. 2021 Dec 1;127(23):4447-4454. doi: 10.1002/cncr.33789. Epub 2021 Aug 11. Cancer. 2021. PMID: 34379792 Free article. Clinical Trial.
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
Zhao N, Ang MK, Yin XY, Patel MR, Fritchie K, Thorne L, Muldrew KL, Hayward MC, Sun W, Wilkerson MD, Chera BS, Hackman T, Zanation AM, Grilley-Olson JE, Couch ME, Shockley WW, Weissler MC, Shores CG, Funkhouser WK, Olshan AF, Hayes DN. Zhao N, et al. Br J Cancer. 2012 Jul 24;107(3):482-90. doi: 10.1038/bjc.2012.264. Epub 2012 Jun 26. Br J Cancer. 2012. PMID: 22735904 Free PMC article.
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Chera BS, Amdur RJ, Tepper J, Qaqish B, Green R, Aumer SL, Hayes N, Weiss J, Grilley-Olson J, Zanation A, Hackman T, Funkhouser W, Sheets N, Weissler M, Mendenhall W. Chera BS, et al. Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):976-85. doi: 10.1016/j.ijrobp.2015.08.033. Epub 2015 Aug 22. Int J Radiat Oncol Biol Phys. 2015. PMID: 26581135 Clinical Trial.
55 results